|
1
|
Xing SZ and Zhang Y: Efficacy and safety
of transdermal fentanyl for the treatment of oral mucositis pain
caused by chemoradiotherapy in patients with esophageal squamous
cell carcinoma. Support Care Cancer. 23:753–759. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo XF, Mao T, Gu ZT, Ji CY, Fang WT and
Chen WH: Clinical study on postoperative recurrence in patients
with pN0 esophageal squamous cell carcinoma. J Cardiothorac Surg.
9:1502014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jing W, Zhu H, Guo H, Zhang Y, Shi F, Han
A, Li M, Kong L and Yu J: Feasibility of elective nodal irradiation
(ENI) and involved field irradiation (IFI) in radiotherapy for the
elderly patients (aged ≥ 70 years) with esophageal squamous cell
cancer: A retrospective analysis from a single institute. PLoS One.
10:e01430072015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu X, Song N, Liu Y, Liu Y, Li J, Ding J
and Tong Z: Efficient induction of anti-tumor immune response in
esophageal squamous cell carcinoma via dendritic cells expressing
MAGE-A3 and CALR antigens. Cell Immunol. 295:77–82. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song B, Cui H, Li Y, Cheng C, Yang B, Wang
F, Kong P, Li H, Zhang L, Jia Z, et al: Mutually exclusive
mutations in NOTCH1 and PIK3CA associated with clinical prognosis
and chemotherapy responses of esophageal squamous cell carcinoma in
China. Oncotarget. doi: 10.18632/oncotarget.6120 [Epub ahead of
print]. 2015.
|
|
6
|
Arigami T, Okumura H, Matsumoto M,
Uchikado Y, Uenosono Y, Kita Y, Owaki T, Mori S, Kurahara H, Kijima
Y, et al: Analysis of the fibrinogen and neutrophil-lymphocyte
ratio in esophageal squamous cell carcinoma: A promising blood
marker of tumor progression and prognosis. Medicine (Baltimore).
94:e17022015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhong Y, Xuan P, Han K, Zhang W and Li J:
Improved pre-miRNA classification by reducing the effect of class
imbalance. Biomed Res Int. doi: 10.1155/2015/960108, Epub 2015 Nov
10.
|
|
8
|
Lu Y, Gao W, Zhang C, Wen S, Huangfu H,
Kang J and Wang B: Hsa-miR-301a-3p acts as an oncogene in laryngeal
squamous cell carcinoma via target regulation of Smad4. J Cancer.
6:1260–1275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taccioli C, Garofalo M, Chen H, Jiang Y,
Tagliazucchi GM, Di Leva G, Alder H, Fadda P, Middleton J, Smalley
KJ, et al: Repression of esophageal neoplasia and inflammatory
signaling by anti-miR-31 delivery in vivo. J Natl Cancer Inst.
107:pii: djv2202015. View Article : Google Scholar
|
|
10
|
Meng XR, Lu P, Mei JZ, Liu GJ and Fan QX:
Expression analysis of miRNA and target mRNAs in esophageal cancer.
Braz J Med Biol Res. 47:811–817. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang M, Liu R, Li X, Liao J, Pu Y, Pan E,
Yin L and Wang Y: miRNA-183 suppresses apoptosis and promotes
proliferation in esophageal cancer by targeting PDCD4. Mol Cells.
37:873–880. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okumura T, Shimada Y, Moriyama M, Takei Y,
Omura T, Sekine S, Nagata T, Shimizu K and Tsukada K: MicroRNA-203
inhibits the progression of esophageal squamous cell carcinoma with
restored epithelial tissue architecture in vivo. Int J Oncol.
44:1923–1932. 2014.PubMed/NCBI
|
|
13
|
Yu X, Jiang X, Li H, Guo L, Jiang W and Lu
SH: miR-203 inhibits the proliferation and self-renewal of
esophageal cancer stem-like cells by suppressing stem renewal
factor Bmi-1. Stem Cells Dev. 23:576–585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sakai NS, Samia-Aly E, Barbera M and
Fitzgerald RC: A review of the current understanding and clinical
utility of miRNAs in esophageal cancer. Semin Cancer Biol.
23:512–521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gadducci A, Sergiampietri C, Lanfredini N
and Guiggi I: Micro-RNAs and ovarian cancer: The state of art and
perspectives of clinical research. Gynecol Endocrinol. 30:266–271.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rawlings-Goss RA, Campbell MC and Tishkoff
SA: Global population-specific variation in miRNA associated with
cancer risk and clinical biomarkers. BMC Med Genomics. 7:532014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Z, Zhang T, Hong H, Liu Q and Zhang H:
miR-202 suppresses proliferation and induces apoptosis of
osteosarcoma cells by downregulating Gli2. Mol Cell Biochem.
397:277–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Zheng D, Xiong Y, Xue C, Chen G,
Yan B and Ye Q: miR-202 suppresses cell proliferation in human
hepatocellular carcinoma by downregulating LRP6
post-transcriptionally. FEBS Lett. 588:1913–1920. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu JJ, Shen XJ, Wang XD and Ju SQ: Effect
of miR-202 on the growth of multiple myeloma cells via regulating B
cell-activating factor and the underlying mechanism. Zhonghua Zhong
Liu Za Zhi. 35:886–891. 2013.(In Chinese). PubMed/NCBI
|
|
20
|
Hu N, Clifford RJ, Yang HH, Wang C,
Goldstein AM, Ding T, Taylor PR and Lee MP: Genome wide analysis of
DNA copy number neutral loss of heterozygosity (CNNLOH) and its
relation to gene expression in esophageal squamous cell carcinoma.
BMC Genomics. 11:5762010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yin X, Zhang R, Feng C, Zhang J, Liu D, Xu
K, Wang X, Zhang S, Li Z, Liu X and Ma H: Diallyl disulfide induces
G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK
pathways in human esophageal squamous cell carcinoma. Oncol Rep.
32:1748–1756. 2014.PubMed/NCBI
|
|
23
|
Zhong C, Fan L, Yao F, Shi J, Fang W and
Zhao H: HMGCR is necessary for the tumorigenecity of esophageal
squamous cell carcinoma and is regulated by Myc. Tumour Biol.
35:4123–4129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang S, Zheng X, He L, Qiao L, Jing D, Ni
Z, Zeng W and Jian M: Significance of SAMD9 expression in
esophageal squamous cell carcinoma. Xi Bao Yu Fen Zi Mian Yi Xue Za
Zhi. 30:411–413. 2014.(In Chinese). PubMed/NCBI
|
|
25
|
Zhang HY, Wang ZQ, Li YY, Wang F, Zeng QR,
Gao Y, Xuan XY and Li SS: Transforming growth factor-β1-induced
epithelial-mesenchymal transition in human esophageal squamous cell
carcinoma via the PTEN/PI3K signaling pathway. Oncol Rep.
32:2134–2142. 2014.PubMed/NCBI
|
|
26
|
Niwa Y, Yamada S, Koike M, Kanda M, Fujii
T, Nakayama G, Sugimoto H, Nomoto S, Fujiwara M and Kodera Y:
Epithelial to mesenchymal transition correlates with tumor budding
and predicts prognosis in esophageal squamous cell carcinoma. J
Surg Oncol. 110:764–769. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wen J, Luo K, Liu H, Liu S, Lin G, Hu Y,
Zhang X, Wang G, Chen Y, Chen Z, et al: MiRNA expression analysis
of pretreatment biopsies predicts the pathological response of
esophageal squamous cell carcinomas to neoadjuvant
chemoradiotherapy. Ann Surg 2015 Oct 1 [Epub ahead of print].
|
|
28
|
Akagi I, Miyashita M, Ishibashi O, Mishima
T, Kikuchi K, Makino H, Nomura T, Hagiwara N, Uchida E and Takizaw
T: Relationship between altered expression levels of MIR21, MIR143,
MIR145, and MIR205 and clinicopathologic features of esophageal
squamous cell carcinoma. Dis Esophagus. 24:523–530. 2011.
View Article : Google Scholar : PubMed/NCBI
|
